I N D I A B E T E S C A R E
n - a - v - i - g - a - t - i - n - g
A N A M C P P A R T N E R S H I P F O R U M
— Hosted by the Academy of Managed Care Pharmacy in partnership with —
J U L Y 1 9 – 2 0 , 2 0 1 6 | R E N A I S S A N C E C A P I T A L V I E W | A R L I N G T O N , V A
INNOVATIONS
On behalf of the Academy, it is my pleasure to welcome you to the AMCP Partnership Forum, Navigating Innovations in Diabetes Care. Over the next day and a half we will develop actionable strategies that address the challenges of integrating recent innovations into diabetes care to improve quality and affordability.
The task before us is very timely. According to govern-ment estimates, more than 29 million Americans have diabetes and nearly 2 million adults are newly diagnosed each year.
Innovations such as remote-monitoring technologies, telehealth and other digital health tools are revolutionizing treatment options, patient engage-ment, accountability and patient-provider interactions. New advances also are addressing medication non-adherence, such as treatments that are injected or implanted in the physician’s office. While such improvements offer hope, they also present significant challenges in the coordination of pharmacy and medical benefits and integrating data sets.
At this forum, we will seek strategies around managing clinical improvements, measurement models, sustainable business and contracting tactics, and communications and engagement plans to best utilize advances and improve diabetes care. Participants will identify gaps in evidence for adopting new technolo-gies in diabetes, and provided recommendations and guidance on the clinical outcomes of importance to managed care organizations.
AMCP will use the resulting recommendations to develop educational programing and tools for Academy members, and to help facilitate the implementation of strategies that improve diabetes care.
Finally, AMCP is grateful for the support of the organizations listed on this page, which makes this Partnership Forum possible.
Thank you for your attendance, and I look forward to a very productive meeting.
Sincerely,
Susan A. Cantrell, RPh, CAECEO, Academy of Managed Care Pharmacy
S P O N S O R A C K N O W L E D G E M E N T S
The Academy of Managed Care Pharmacy wishes to thank the following organizations for their generous support of this AMCP Partnership Forum.
INNOVATIONS
n - a - v - i - g - a - t - i - n - g
I N D I A B E T E S C A R E
THANK YOU
T O O U R D I S T I N G U I S H E D P A R T I C I P A N T S A N D G U E S T S
The Academy of Managed Care Pharmacy looks forward to holding more partnership forums focused on issues of greatest importance to our 8,000 members, the more than 200 million Americans covered by the pharmacy benefit, and other health care stakeholders. #AMCPdiabetes
A G E N D A - A T - A - G L A N C E
8:00 am – 9:00 am BREAKFAST
9:00 am – 9:30 am Welcome and Introductions Susan A. Cantrell, RPh, CAE Mary Jo Carden, RPh, JD Dana Regan, MBA, Moderator
9:30 am – 10:00 am Presentation: Diabetes Trends — Prevalence, Incidence, Pharmacy and Medical Integration Starlin Haydon-Greatting, MS, BSPharm, CDM, FAPhA
10:00 am – 10:30 am Discussion: Opportunities and Challenges in Diabetes Trends
10:30 am – 10:45 am BREAK (coffee/tea)
10:45 am – 12:00 pm Panel: Advances in Diabetes Treatment and Contracting Strategies Caleb Alexander, MD, MS Brandy Fouts, PharmD Aaron Kowalski, PhD Sandra O’Keefe, MPH, CWC
12:00 pm – 12:45 pm NETWORKING LUNCH
12:45 pm – 1:30 pm Breakout Session #1: Strategies for addressing advances in diabetes treatment
1:30 pm – 2:00 pm Discussion: Breakout Session #1 Report Out
2:00 pm – 2:10 pm AFTERNOON BREAK (coffee/snacks)
2:10 pm – 3:15 pm Panel: Innovations in Care Models — Impact on Quality Sarah Ahmad, MA, MBA Jody H. Allen, BS, PharmD, FASHP Kendra Gaskins Daniel J. Kent, PharmD, CDE
3:15 pm – 4:00 pm Breakout Session #2: Strategies for maximizing innovative care models and tactics for quality improvement
4:00 pm – 4:30 pm Discussion: Breakout Session #2 Report Out
4:30 pm – 4:35 pm DAY 1 WRAP-UP
8:00 am – 8:30 am BREAKFAST
8:30 am – 8:35 am Welcome Back and Introduction of Day 2 Goals
8:35 am – 10:00 am Panel: What are You Looking for in Terms of Value with New Diabetes Tools? Kevin A. Clauson, PharmD Wenni Haley Malinda Peeples, MS, RN, CDE Ava Runge
10:00 am – 10:10 am BREAK (coffee/tea)
10:10 am – 11:00 am Breakout Session #3: What are the gaps in evidence to adopting new technologies? What clinical outcomes (beyond HbA1c) are important to managed care stakeholders?
11:00 am – 11:30 am Discussion: Breakout Session #3 Report Out
11:30 am – 11:45 am Summary of AMCP Partnership Forum on Diabetes: Findings and Discussion on Next Topics and Steps for AMCP
11:45 am – 12:00 pm THANK YOU AND WRAP-UP
D A Y 1 | T U E S , 7 / 1 9 D A Y 2 | W E D , 7 / 2 0
Dana Regan, MBAPrincipal Market Access Communications LLC
A B O U T T H E M O D E R A T O R
Judy Crespi-Lofton, MSPresident JCL Communications, LLC
A B O U T T H E W R I T E R
#AMCPdiabetes
Introducing the World’s First Continuous Glucose Monitoring (CGM)
System on the Phone
CGM reveals what no meter can. Unlike fingersticks that give a number for a single point in time, CGM lets you see your glucose in real time so you’ll always know when your glucose is trending
high, low or when you’re good to go.**
And now, with Dexcom G5 Mobile CGM System, viewing your data is easier than ever. With glucose information displayed directly onto your smart phone,*** you’ll get the ultimate in
convenience and discretion.
Always know with Dexcom G5 Mobile CGM System.
See glucose in a whole new way with
Dexcom G5® Mobile CGM
System*
To learn more, visit dexcom.com/G5Mobile.
BRIEF SAFETY STATEMENTThe Dexcom G5 Mobile Continuous Glucose Monitoring System (the “System”) is a glucose monitoring system indicated for detecting trends and tracking patterns in persons (age 2 years and older) with diabetes. CONTRAINDICATIONS Remove the System (sensor, transmitter, and receiver) before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or high-frequency electrical heat (diathermy) treatment. The System is MR Unsafe. Do not bring any portion of the System into the MR environment. Taking acetaminophen while wearing the sensor may falsely raise your sensor glucose readings. WARNING Do not use the System for treatment decisions. The System does not replace a blood glucose meter. The System is not approved for use in pregnant women, persons on dialysis or critically ill persons. If a sensor breaks and no portion of it is visible above the skin, do not attempt to remove it. Seek professional medical help if you have infection or inflammation. Report broken sensors to Dexcom Technical Support. Sensor placement is not approved for sites other than under the skin of the belly (ages 2 years and older) or upper buttocks (ages 2-17 years). Your smart device’s internal settings override your Dexcom app settings. Accessory devices (like a smart watch) might override your smart device’s alert and notification settings. The Share feature must be turned “On” with an active internet connection to communicate glucose information to a Follower. The Follower must download and install the Dexcom Follow App onto a separate smart device with an active internet connection to receive data. Contact Dexcom Toll Free at 877-339-2664 or www.dexcom.com for detailed indications for use and safety information.
* Dexcom G5 Mobile Continuous Glucose Monitoring System, User’s Guide, 2015.** The Dexcom G5 Mobile CGM System does not replace a blood glucose meter. Always use the values from your blood glucose meter for treatment decisions.*** To view a list of compatible devices, visit www.dexcom.com/compatibility ©2016 Dexcom Inc. All rights reserved.
LBL014135 Rev001
LBL014135 PAY-014 AMCP Ad.indd 1 6/28/16 5:04 PM
M
pp AgauS Tmcsas DBA
F
m
B
C
Moderat
payer insightsprojects.
After initially gaining payer and conducteunderstandingSGLT2 and GL
To build uponmarkets in decommunicatiospecialty and aspects of paystate educatio
Dana receivedBiology from tAssociation an
Forum W
medical comm
Behavior from
Communicatio
tor DanaPrincMark Danaprodthe pcomm
s programs in
working for minsights to ind over 100 pag through heLP1s.
n her payer knveloping payon firms whesmall molecuyer communion initiatives,
d her Master the Universitynd was recog
Writer
Judy CPresidJCL Co Judy C
consu
educa
JCL Co
munications c
m the Univers
on from Drex
a Regan, MBAcipal ket Access Co
a has been foduct developmpast fifteen yemercialize procluding advis
manufacturernform her clieayer advisoryr work with B
nowledge, Daer communicre she managule product lacation includ and physicia
in Business Ay of Californianized as a Ris
Crespi‐Loftondent ommunicatio
Crespi‐Lofton
ulting compan
ation materia
ommunicatio
company. Ms
ity of Pennsy
xel University
A
ommunication
cused on payment, medicaear, her focusoducts, with tsory boards, f
rs of pharmacents with Medy programs foBD diabetes e
na shifted hecation programged client servaunches. She ing disease awn pull‐throug
Administrationa, San Diego. sing Star in 20
n, MS
ns, LLC
n, MS, is Presi
ny. Ms. Cresp
ls for health c
ns, LLC, she w
. Crespi‐Lofto
lvania, and h
.
ns
yer communicl devices, bios has been onthe payer neeocus groups,
ceuticals and diMedia Manor her client bducation, rap
er activities toms. Dana wovices for multbrings expertwareness, progh optimizatio
n from PeppeShe is activel007.
dent of JCL C
i‐Lofton has o
care professio
was Scientific
on earned her
er master’s d
cations in varotech and comn partnering weds as the fouonline survey
medical devicaged Care. Dbase. Dana hapid and long a
o leverage heorked for sevetiple manufactise in the oveoduct launchon and tactics
erdine Univerly involved in
Communicatio
over 20 years
onals, and re
Project Man
r bachelor’s d
degree in Tech
rious roles in mmercializatiowith manufacundation. Days, and telep
ces, Dana shiDuring this timas extensive dacting insulins
r understanderal leading mcturer clientsersight and d expertise, qus.
rsity and a Ban the Healthca
ons, LLC a me
s’ experience
lated materia
ager at Trinit
degree in Biol
hnical and Sci
pharmaceuticon since 1994cturers to ana has led mhone market
fted her focume, Dana devdiabetes s, metformin,
ding of the pamanaged mars and led seveevelopment ouality and dis
chelor’s degrare Businessw
edical writing
developing c
als. Prior to fo
ty Communica
ogical Basis o
ientific
cal 4. Over
multiple research
us onto veloped
, DPP4is,
yer rkets eral of many ease
ree in women’s
and
continuing
ounding
ations, a
of
POD THERAPYThe control of a pump. The comfort & convenience of the Pod.
Manage diabetes with freedom and simplicity.
*Up to 72 hours of insulin delivery.**The Pod has an IPX8 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. ©2016 Insulet Corporation. All rights reserved. 17519-AW R1
Kelly L.Kelly L.Kelly L.
SINCE 2014
Lexi B.Lexi B.Lexi B.
SINCE 2013
Up to 3-Day Continuous Wear*
Hands-free Insertion
Integrated Blood Glucose Meter
Discreet and Flexible
Waterproof**
Cleared for All Ages
TM
TM
SEispcpe NtPPMP
e SlecatSME
Services since Evidence Analynclude condusupport the fopharmaceuticacost, and impapromoting evieffective use o
Natalie receivethe University Pharmacy in 2Pharmacy PracMedical CentePharmacother
easier for peop
She has workeeads Consumecompany’s Innand externallyto improve anShe holds a BAManagement aEntrepreneurs
Natalie BCPS PharmaStrategiServices Natalie ABCPS haPerman
2014. In her ryst and Stratecting clinical eormulary proceals and forecaact on other avdence‐based pof pharmaceut
ed her Doctor of the Pacific 007. She comctice PGY1 Reser and is boardrapy.
Sarah AhVice PreInnovati Sarah is healthcawith a paproducts
ple to achieve
ed for Humanaer Health Solunovation teamy to build and sd sustain HumA in Psychologand an MBA wship.
Aboubechara
cist Evidence Ast, Drug Informs, Kaiser Perm
Aboubechara,as been with Kente (KP) Drugrole as a Pharmegist, her respoevidence revieess, evaluatingsting market available theraprescribing anticals.
of Pharmacy Thomas J. Lonpleted a Manasidency at KP d certified in
hmad, MA, Msident, Humaon, Humana
an accomplishare explorer anassion for co‐cs and servicese their best he
a for 20 years utions (CHS), am. CHS partnerscale integratemana membery, an MA in Hwith focus on
Pa, PharmD,
Analyst and mation anente
, PharmD, Kaiser g Informationmacist onsibilities ews to g pipeline availability, pies while nd cost‐
degree from ng School of aged Care Sacramento
MBA na Health
hed nd leader creating that make it alth.
and currentlya part of the rs internally ed solutions rs’ health. ealth Services
Part
y
s
BloofounEffecHopkand care authprescDr. AUnivReseUniv
for ocommand mScripserveGoveHealPresi Jody NortPharCom
ticip
mberg Schoolnding co‐Directctiveness and kins Center ofInnovation (JHphysician andor of over 190cription drug Alexander receversity of Pennerve Universityversity of Chica
our health planmercial healthmanaged Medpts in 1998 as ed as Vice Preernment and Lth Plans/Manident, Public P
y holds a B.S. inth Carolina at rmacy from Mmonwealth U
panCaleb AlexaCo‐Director,for Drug SafJohns Hopkiof Public He Dr. AlexandeProfessor ofMedicine at
l of Public Heator of the CenPrincipal Invef Excellence inH‐CERSI). He isd pharmacoep0 scientific artutilization, safeived his B.A. nsylvania, an My, and a Masteago.
Jody H.FASHP Vice PreAccounExpress Jody H. PresideManageDivisionShe lead
ns at Express Sh plan clients, dicaid groups.a clinical accoesident, ClinicaLabor group; Enaged MedicaiPolicy and Ext
n Pharmacy frChapel Hill anedical College
University.
ntsander, MD, MS, Johns Hopkinfety and Effectins Bloombergealth
er is an Assocf Epidemiologyt the Johns Hoalth, where henter for Drug Sestigator of then Regulatory Ss a practicing pidemiologist ticles examininfety and effeccum laude froMD from Caseer of Science f
Allen, BS, Ph
esident, Clinict Managemens‐Scripts
Allen serves ant, Clinical Acement in Healn at Express Scds the clinical Scripts, which Medicare, Ex. Since joiningount executiveal Services, Executive Direid groups, andernal Affairs.
rom the Univend a Doctor of e of Virginia/V
S ns Center tiveness, g School
iate y and opkins e serves as Safety and e Johns cience primary and the ng ctiveness. om the e Western from the
armD,
cal nt,
as Vice ccount lth Plan cripts. strategy includes xchanges Express e, she has
ector for d Vice
ersity of
Virginia
For more information on the Company, please visit www.intarcia.com.
Intarcia Therapeutics is a rapidly emerging biopharmaceutical company committed to developing innovative therapies that merge medicine with technology and have the potential to transform therapeutic categories.
TIME DISRUPTTM2© 2016 Intarcia Therapeutics, Inc. All rights reserved. 07/16
S:7.5”S:10”
T:8.5”T:11”
B:8.75”B:11.25”
phsnpdcMPjoAH
iipsRPdSca
physician netwhe oversees thservices and wnetwork. He mprimary care odegree from thcompleted a reMedicine/EndPharmacy andoining StewarACPHS and as Hospital.
n Columbus, Omplementatiopharmacy careshe acts as theResources, thePBM vendor indesigns, servicState Universitcommittees reand technolog
EdwardSenior MWellnesNetwor Dr. EdwManageWellnesNetwor
work in Massahe teams provwellness coachmaintains a clioffices. Dr. Allhe University esidency in Amocrinology at Health Sciencrd in this role, Clinical Coord
AmandMBA DirectoManageUnivers Amandais the DCare MaState U
Ohio. In her roon, and evaluae managemene clinical liaisoe OSU Wexnern support of pces, and commty. She has seegarding pharmgy.
d Allie, PharmManager of Phss, Steward Hek
ward Allie is theer of Pharmacss for Stewardk, the second chusetts. In tviding clinical phing for patiennical practice ie received hiof Rhode Islanmbulatory CarAlbany Collegces (ACPHS). he served as fdinator at Norw
a Bain, Pharm
r, Pharmacy aement, The Ohsity Health Pla
a Bain, Pharmirector of Phaanagement foniversity Healole, she leads tation of nursinnt programs. Aon to the Officer Medical Centharmacy benemunications forved on numemacy educatio
PD, BCPS harmacy and ealth Care
e Senior y and d Health Care largest his capacity, pharmacy nts in the within s PharmD nd and re/Adult ge of Prior to faculty at wood
mD, MPH,
nd Care hio State n, Inc.
D, MPH, MBAarmacy and or The Ohio th Plan, Inc. the creation, ng and Additionally, e of Human ter, and the efit program or The Ohio erous nationalon, quality,
Part
A
whosTher Kevinfromresidsubsand peducfor Efor eDirecjoinin
with CalifoDirecform(MedInsurNatioClinicInforto phreseadevenervat thyears
ticip
se pharmacy brapeutics.
n received undm the Universitdency at the Uequently devepopulation hecation at the UExcellus Blue Ceight years as ctor then Outcng Prime Ther
MedImpact Hornia for the pctor of Clinica
mulary managedicare Part D, rance Exchangonal Pharmaccal Pipeline, Srmation and Dharmacy, she arch institute elopment addrous system. She Human BioMs.
panKevin L. BoPrincipal HeResearcherLLC Dr. Bowen studies thaand medicaadministrat
benefits are a
dergraduate aty of Iowa, theUniversity of Veloped interesealth and receUniversity of RCross Blue ShieDrug Utilizatiocomes Prograrapeutics in 20
Lisa CashmaDirector ClinMedImpact Lisa Cashmathe UniversDiego and athe UniversFrancisco. L
Healthcare Syspast 8 years. Il Services, sheement, strategCommercial, ge), Co‐Chairmy and TherapeSpecialty Drug Drug Data Manco‐founded a specializing inressing diseasShe served as CMolecular Res
ntsowen, MD, MBealth Outcomr, Prime Thera
designs and pt integrate phal insurance tive claims of dministered b
and medical den an internshVirginia. He sts in health eeived additionaRochester. He eld in Rocheston Review Prom Director be012.
an, PharmD nical Formular Healthcare Sy
an received a ity of Californa PharmD degrity of CalifornLisa Cashman stems in San Dn her current e has responsigy and executMedicaid, Heman of the Meeutics Commitmanagementnagement. In non‐profit bion pre‐clinical dses of the centChief Executivsearch Institut
BA es apeutics
performs harmacy
members by Prime
egrees hip and
economics al worked ter, NY, ogram efore
ry, ystems
B.A. from ia, San ree from ia, San has been Diego, role as ibility for ion alth edImpact ttee, t, Drug addition omedical drug tral ve Officer te for 6
fIdChiRURK
iHtaFpPmph
founding direcnformatics Redesignated as Collaborating Chealth and hasncluding the NRadio. He receUniversity of TResearch FelloKansas City.
mmediately pHospital Celebthe completioan Assistant PrFAMU. In 2012position as a cPlans, Inc. whemanagement spopulation. Shher husband a
Kevin AAssociaUnivers Kevin AassociatUniversand HeaTN and
ctor of the Cenesearch, whicha World HealtCenter. His res generated coNew York Timeeived his DoctoTennessee – Mowship at the
JameekClinical Health P Dr. Jameclinical pHealth PreceivedA&M Un
pursued a PGYbration Healthn of her residerofessor posit2, Dr. Devoe‐Mlinical pharmaere she providservices to thehe currently rend daughters
A. Clauson, Phte Professor, sity
A. Clauson, Phate professor asity College of alth Sciences ihis previous rnter for Consuh was the firstth Organizatiosearch is focuoverage by soes, Forbes.comor of PharmacMemphis and cUniversity of M
a Devoe‐MorPharmacist, WPlans, Inc
eeka Devoe‐Mpharmacist atPlans, Inc in Tad her PharmDniversity in 201 residency at in Orlando, Fency in 2009, ion at her almMorris then acacist at WellCades medicatione Medicaid anesides in Tamp.
ParmD Lipscomb
armD, is an at Lipscomb Pharmacy in Nashville, roles include umer Health of its kind on sed on digitalurces m, and BBC cy from the completed a Missouri –
ris, PharmDWellCare
Morris is a WellCare ampa, FL. She from Florida 008 and then t Florida L. Following she accepted
ma mater, ccepted a are Health n therapy nd Medicare pa, FL with
Part
EducWayof Cerecog Nancdiabeshe hpolicstaff assisAscethe a
of thRegioof thvolunSocieAfricphys2014bioloher mEdwaAdma foc
ticip
cators. She reyne State Univertified Diabetgnized fellow
cy presently wetes educatorhelps with hoscies around glyf and patient ests in safety anension Health acute care set
he internal meonal Hospital.he Jefferson Awnteerism. Sheety's Journey tcan American sician of the ye4. She receivedogy from the Umedical degreards also has a
ministration frocus on Six Sigm
panNancy D’HonStaff/Clinical Diabetes EduProvidence HCenter Nancy D’Honcurrent PresiAmerican Ass
eceived her B.Sersity in Detrotes Educator (of AADE.
works as a clinr at St John Hospital inpatienycemic manageducation. Adnd formulary dSystem relatetting.
Anita EdwaMedical DirPlan Physician AM.B.A., servat Gatewaybeen a doctMedical Ass
edicine depart. In May of 20ward for excee is a mentor tto Medicine Pmedical studeear for Gatewd her undergrUniversity of Pee from Howaa master's degom the Univerma processes.
ntsndt, RPh, CDE,Pharmacist a
ucator, St JohnHospital and M
ndt serves as tdent‐elect of sociation of DS. in pharmacyoit, holds the (CDE) and is a
ical pharmacisospital in Detrnt protocols angement and pdditionally, Nadecisions for ted to glycemic
ards, MD, MBArector, Gatewa
Anita Edwards,ves as Medicay Health. Edwator with Centusociates and wment at Jeffe15, she was thellence in healto the GatewaProgram for yoents. She was way Medical Soraduate degrePittsburgh, andrd University. gree in Businersity of Tennes
, FAADE nd n Medical
he the iabetes y from credential
st and oit. Here nd rovides ancy the control in
A ay Health
, M.D., al Director ards has ury III was chair rson he receipt th care y Medical oung named ociety in e in d received Dr. ess ssee with
rastrBapMOs
oaMMrmthiiriBMpcmo
relationships, analytics and pspecialty drug the pipeline anresidency progBrandy was that Group Healtplan and deliveMedication ThOverutilizationstrategies that
of the Payer Stacquisition of Medicine in 20Medical Officeresponsible fomedical stratethe Hobart Grohas over 24 yendustry and ancluding popuresearch with nstruction tecBachelor of ScMaster of Sciepathology fromclinically trainemedical degreof Medicine &
BrandyClinical Specialt Brandy 2014 asConsultspecialtshe ma
and collaboraproduct teamsmanagementnd serves as agram as well. Pe Medicare Clth Cooperativery system, wherapy Managn programs in t supported M
DominicChief MeValue Dominic Chief Meand PopuPrecision
trategic ServicHobart Group013, he serveder of Hobart Inr supporting tegies, productsoup Holdings ears of experien extensive caulation‐based the applicatiochnology. Dr. Gience in mechence in epidemm SUNY at Bufed as a generae from the Un Surgery.
y Fouts, PharmPharmacy Coty Medication
Fouts joined s a Clinical Phatant with an ety medicationnages specialttes with clinics to design ant solutions. Sh preceptor forPrior to joininlinical Servicese, an integrat
where she overement and Opaddition to cl
Medicare 5 Sta
Galante, MDedical Officer,
Galante, MD,edical Officer oulation Healthn for Value ances team. Priop Holdings by Pd in a similar rnnovations, whthe developmes, benefits, anportfolio of buence in the heareer in manabehavioral moon of computeGalante receivhanical enginemiology/experffalo. Dr. Galaal surgeon andniversity of Pa
PmD nsultant, ns, OmedaRx
OmedaRx in armacy mphasis in s. In this role, ty pharmacy cal, sales, d implement e manages r the g OmedaRx, s Coordinatored health rsaw the pioid inical r.
D, MS Precision for
, MS, is the of Quality h Solutions at d a member or to the Precision for ole as Chief here he was ent of d policies for usiness. He althcare ged care, odification er‐assisted ved his ering and imental ante is d received his lermo School
Part
execnatioUp/Pcampdetesecomilliocommand sfor mevalu
appliDexcfor vsystemondegrCalifo
ticip
cution of all asonal health caPressure Downpaign to improection, and connd campaign on people witmunications asponsor devemedical groupsuation compo
ications for UScom, she has lvarious marketem of mobile itoring. Wennree in Microbioornia, San Die
panKendra GaskDirector, NatCampaigns, A Kendra GaskJune 2013, asHealth CampAMGA, Kendimplementat
spects of the Fmpaigns—whn® its first throve high bloontrol; and Togaimed to impth Type 2 diaband outreach slopment, edus and consumonents.
Wenni HaleManager ofDexcom, In Wenni HaleRegulatory where she ideveloping regulatory s
S new produced successful ted products, medical apps ni received a Bology from thego.
ntskins tional Health AMGA
ins joined thes Director, Napaigns. In her ra oversees thtion and on‐goFoundation’s thich include Mee‐year natiod pressure pregether 2 Goal®rove care for betes. She leadstrategies, pacational progr
mers, and resea
ey f Regulatory Ac.
ey is a ManageAffairs at Dexis responsible and executingstrategies andts. Since joininregulatory suincluding the for continuouBachelor of Scie University o
AMGA in tional role at he oing two Measure nal evention, ®, the one ds all rtnership ramming arch and
Affairs,
er of xcom, Inc., for g d ng ubmissions first
us glucose ience of
CepmMwapic AphwpmAF
oecwdfd
Clinical Prograestablish ambuprograms to immedication opManagement which includesand cardiovascpharmacist‐bansured emplocardiovascular
As a pharmacipharmacoepidhealth care ouwith over 25 ypharmacy claimmanagement. Alliance (PQA)Forum (NQF) E
oversight of alendocrinologycare. His role iways to delivedrugs. Implemforecasting, tradollar budgets
StarliBSPhDirecIllinoiPatieProgr HaydIllinoiAssoc
ms, working pulatory care mmprove patienptimization. AProgram (PSMs programs focular health aased care manoyers in pre‐dir health, asthm
st who speciademiology, sheutcomes reseayears’ experienms analysis an She serves o workgroups aEndocrine Stee
DanCooPhaHea CurrspeccoocareNortHe i
l drugs associy, infectious dis to implemenr health care
mentation incluacking pipelins, training pati
in Haydon‐Grearm, CDM, FActor of Clinical is Pharmacistsnt Self‐Managram
on‐Greatting is Pharmacistsciation’s (IPhAprimarily to crmedication mant centered cas the IPhA Pat
MP) Network Cr diabetes, prend coaches’ pagement progabetes, diabetma, and depre
lizes in e is an expert rch and drug‐nce with medind population n the Pharmaand the Natioering Committ
niel J. Kent, Phrdinator Specrmacy Progralth
rently, Daniel cialty clinical prdinator for a e organizationthwest for oves responsible ated with diabseases, hepatnt new and inusing expensivudes health ples, managing ents and staff
Peatting, MS, APhA Programs, s Association, gement
serves as the s A) Director of reate and anagement are and tient Self‐Coordinator, e‐diabetes, atients in the gram for self‐tes, ession.
in the field of ‐use analysis, ical and health cy Quality nal Quality tee.
harmD, CDE cialty Clinical m, Group
J. Kent is a pharmacy managed in the Pacific er 35 years. for clinical betes, titis and HIV novative ve designer an multi‐million f, and
Partestab1100and ninfeccons
JDRFcombwith diabechamworl Dr. Kthe aleademultaccedelivon Tstudyreveamon
serviintegsettiintegorga
ticipblishing polici0 patients for new diabetes ctious diseasesultation to sp
F and the broabines his profhis personal eetes (T1D) formpion JDRF’s pd without T1D
Kowalski is an area of diabeter of JDRF’s Ati‐million dollalerate the provery systems. 1D research ay in The New aled the effecitors in T1D m
ices nationallygrated clinical ngs including grated behavionizations and
panes. He also prinsulin pumpsdrugs. He hass, vaccines, hepecialist and p
Aaron KowaChief MissioResearch, JuResearch Fo Aaron J. Kowappointed JMission offiand serves a
ad diabetes cofessional expeexperience ofr over 30 yearsprograms focuD.
internationalltes technologiArtificial Pancrear initiative thaogress towardHe has authorand was a coauEngland Journctiveness of comanagement.
Sandra Leal, CDE Vice PresidenSinfoniaRx Dr. Leal is theInnovation atof medicationy. She is worki pharmacy sea hospital discoral health clipatient‐cente
ntsovides care tos, complex inss a similar roleepatitis and primary care pr
alski, PhD on Officer & Vuvenile Diabetoundation
walski, Ph.D., wDRF’s first Chicer in Decembas a key link bommunity. Dr.rience as a scif living with tys to help guidused on creati
ly recognized es and has beeas Research at began in 20 automated inred numerousuthor of the lanal of Medicinontinuous gluc
PharmD, MPH
nt for Innovati
e Vice Presidet SinfoniaRx, an therapy maning to establisrvices in a varcharge progranics, accountaered medical h
o over ulin plans, e for rovides roviders.
P, tes
was ief ber 2014 etween Kowalski ientist pe 1 e and ing a
expert in een a Project, a 005 to nsulin‐s articles andmark ne that cose
H, FAPhA,
ion,
ent for a provider nagement sh riety of am, able care homes.
SrwiSt
PsamDpoADmsps
MGfoppPaW
She is utilizing resources to cowork has beenn Chronic KidnSystem Pharmthe Institute o
Pharmacotherstudies to asseand pharmacismanagement tDr. McAdam‐Mpublications anof Managed CaAdvisory BoardDr. McAdam‐Mmanaged careshe developedprograms, andstrategy analy
Management General Hospifor the past 11operational aspreventative pprimary care. SPublic Health fand her CertifiWellcoaches, I
tele‐health anommunities, cn published in ney Disease, A
macy and a discf Medicine.
Carrie MAssociateUtah Col Carrie Man AssocUniversit
rapy. She condess the value ost‐led compreto support heaMarx has over nd is currentlyare & Specialtd. Prior to joinMarx had an e and pharmacd disease and d led drug pricses.
Sandra OProgramHealth MCare, MaHospital Sandra ODirector
in Primary Cartal in Boston, 1 years. In thisspects of chronpopulation heaSandra receivefrom the Univicate in WellneInc.
nd other stratclinicians, andDiabetes CareAmerican Jourcussion paper
cAdam‐Marx,e Professor, Ulege of Pharm
cAdam Marx, iate Professorty of Utah Depducts outcomeof diabetes mehensive medicalthcare decis25 diabetes‐ry a member ofty Pharmacy Ening the Univestablished carceutical industutilization maing and contra
O’Keefe, MPHm Director, PopManagement iassachusetts G
O’Keefe is the r for Populatiore at MassachMA where shs role, she direnic disease analth managemed her Masterversity of Massess Coaching f
Ptegies to scale patients. Here, Advances rnal of Health‐published by
, PhD, RPh niversity of
macy
PhD, RPh, is r with the partment of es research edications cation sion making. related f the Journal Editorial ersity of Utah, reer in the tries where nagement acting
H, CWC pulation in Primary General
Program on Health husetts e has workedects the d
ment in r’s Degree in sachusetts from
Part r
‐
profehealtplatfthat chroAdjuInforPrevAmeprofeadva
for thStepconsEPA.
ticip
essional organthcare compaform to createimpact healthnic disease mnct Assistant rmatics, Johnsiously, Peepleerican Associatessional memancing the pra
he diabetes bhanie workedsulting compan
panMalinda VP Clinica Malinda serves asClinical Awhere shoutreachresearch
nization activitany leveraginge clinical and bh and economanagement. PFaculty, Divisis Hopkins Schoes served as prtion of Diabetbership organctice of diabe
Stephanie PoAssociate DirManaged Car Stephanie haat Merck for various sales In her currenon Managed rands. Prior td at an environny on Superfu
ntsPeeples, MS, al Advocacy, W
Peeples, RN, Ms Vice PresidenAdvocacy at Whe oversees th program, graactivities, andties. WellDocg the mobile tebehavioral solmic outcomes fPeeples also sion of Healthcool of Medicinresident of thtes Educators nization devotetes education
onzo rector Marketre, Merck & C
as worked on dover 10 yearsand marketin
nt role StephanCare Brand Mto her time winmental enginund projects fo
RN, CDE WellDoc
MS, CDE, nt for
WellDoc he clinical ant and d c is a echnology utions for serves as care ne. e (AADE), a ted to n.
ing – o., Inc.
diabetes s in ng roles. nie works Marketing th Merck, neering or the
aarspddte
MMsdcreapdDfP
advocating forat Close Conceresearch and psubscription‐bprofessionals idiabetes camediabetes in 20the greater diaeducation, and
Medicaid clienMedical Schoosupervises a tedeveloping ancomprehensivresponsible foevaluation andactive with Cliprogram, actinduring a MassDr. Tesell recefrom the UnivePharmacy in 2
Ava RunSenior AFoundat Ava RunThe diaTnonprofthe livesprediabe
r action. Prior erns covering dproduct news based newslettin the field. Ave from her ow10, which inspabetes commud advocacy.
Mark TeClinical CLead, UnCommoPharmac Mark Teclinical csupervis
nt at the Univeol’s Clinical Pheam of pharmd maintaininge clinical guidr staff trainingd coordinationnical pharmacng as a primarHealth prograived his Doctoersity of Conn007.
nge Associate, Thetion
nge is a senior Tribe Foundatfit focused on s of people wietes, and obeto joining TdFdiabetes techfor Closer Looter read by thva’s initial inten diagnosis wpired her to geunity through
esell, PharmD,Consult Pharmniversity of Manwealth Medicy Services
esell, PharmD,consultant phasor for the Maersity of Massaarmacy Servicacists responsg clinical initiatelines. In this g, developmenn of workload.cy services resy preceptor foam experientiaor of Pharmacnecticut’s Scho
P
diaTribe
associate at ion (TdF), a improving th diabetes, sity and F, she worked nology ok, a ousands of erest in ith type 1 et involved in research,
, BCPS macist Team assachusetts, icine: Clinical
BCPS is the armacist assachusetts achusetts ces unit. He sible for tives and role, he is nt and . He is also sidency or residents al rotation. cy degree ool of
PartDaniVice DaniCarebase2000with care goveInsulcare respoand nbasevarioPhar
Dexcfor stimpleKey Ncompprodyearshealtwith leadeDirecDevereceiBarb
ticipiel Trodden President, Ma
el Trodden see at Insulet Cored in Billerica, 0 with the misdiabetes. Mrorganizations
ernment and slet Corporatioroles at Genoonsible for leanegotiate in‐ned reimbursemous sales and mrmaceuticals, I
com, Inc. In ttrategically asementing accNational payepany awareneduct. Erica hass focused on bth plans. PrioJohnson and ership, includictor, North Amelopment andived a B.A. frobara.
pan
arket Access,
erves as Vice Prporation, a mMassachusettssion of impro. Trodden hass ranging fromstrategic markon, he served iomic Health, Inading the effonetwork statusment rates. Hemanaged careInc. and U.S. H
Erica WilliamNational AccDexcom Erica WilliamExecutive, recontracting Plans and PB
his current rossessing, deveount specific ers and Nationess and adopts spent the mabuilding partnor to Dexcom, Johnson, withing; District Mmerica Field Sa Payer Accounom University
nts
Insulet Corpo
President of Mmedical devicets that was foving the lives s worked withm private payokets. Prior to hin several mannc., where he orts to secure cs and payor vae previously see roles at CytyHealthcare.
ms count Executiv
ms, National Aesponsible forwith NationalBMs on behalfole Erica is respeloping and plans and tactnal PBMs to drion of CGM/Dajority of the nerships with nshe spent 13 h increasing roManager, Assocales Learning nt Manager. of California a
ration
Managed e company unded in of people managed
ors to his role at naged was coverage alue‐erved in yc, Tap
ve,
Account r Health f of ponsible
tics with rive Dexcom last 10 national years oles of ciate & Erica at Santa
w2cSPIssdc
RPAHGbeawritftQPHtf
went on to gra2014 with his completed a PServices in CorPGY‐2 residencntermountainstayed with Intservices in a pdiseases such collaborative d
RPh, joined IntPresident and Analytics. Dr. HEOR and MedGlobal leadersbiotechnologyextensive expeas well as all aworld” evidenreported outcomprovement.the National Qfor Ambulatorthe Research CQuality AlliancPhD in Health Hopkins Bloomthe University from the Unive
Bradly WAmbulaPharmaHealthc Brad wahis fathethat owindepen
aduate from thDoctor of PhaPGY‐1 residencrvallis, OR. Hecy in Ambulatn Healthcare intermountain Hrimary care clas diabetes andrug managem
KristinaRPh Vice PreGeneratTherape Kristina
tarcia TherapeHead of EvideYu‐Isenberg hdical Affairs exship roles at phy and managedertise across mspects of outcce, including eomes, econom She previou
Quality Forum y Care MeasuCoordinating Cce (PQA). Dr. YServices Resemberg School oof Massachusersity of North
Winter, Pharmtory Care Clincist, Intermouare
as raised in pher, who is a phned and operndent pharmahe University rmacy degreecy with Samare went on to ctory Care withn Salt Lake CitHealthcare to inic where he nd hypertensioment agreeme
Yu‐Isenberg,
esident, Evidention & Analyticeutics
Yu‐Isenberg, eutics in July 2ence Generatihas more thanxperience in bharmaceuticad care companmultiple theracomes researceffectiveness, mic evaluationusly served as (NQF) Steerinres and was CCouncil for theYu‐Isenberg rearch from theof Public Healsetts; and BS ih Carolina at C
PmD ical untain
harmacy by harmacist ated an cy. Brad of Utah in e, then ritan Health complete a y, Utah. He start clinical manages on under ents.
PhD, MPH,
nce cs, Intarcia
PhD, MPH, 2016 as Vice on & n 15 years of both US and l, nies. She has peutic areas ch and “real‐patient‐
ns and quality a member of ng Committee Co‐Chair of e Pharmacy eceived her e Johns th; MPH fromn pharmacy Chapel Hill.
Part
m
AcaPha SusaChief MaryVice EmilyProg AshleManProg AmyDirec SusaAssis TerryDirec JuliaProje
ticip
ademy ofarmacy S
an A. Cantrell,f Executive Of
y Jo Carden, RPresident of G
y DeLauder gram Coordina
ey E. Lanhamager of Studegrams
y O’Connor, CMctor of Meetin
an Oh, PharmDstant Director
y Richardson,ctor of Produc
Veeder ect Planner &
pan
f ManageStaff
RPh, CAE fficer
RPh, JD Government &
ator, Business
, PharmD, MBent Developme
MP‐HC, DES ngs & Convent
D, MS of Pharmacy
, PharmD, BCAct Developme
Website Coor
nts
ed Care
& Pharmacy A
Development
BA ent & New Pra
tions
Affairs
ACP nt
rdinator
Affairs
t
actitioner
100 N Pitt Street | Suite 400 | Alexandria, VA 22314www.amcp.org
#AMCPdiabetes
